The Asia Pacific Dry Eye Treatment Devices Market would witness market growth of 8.2% CAGR during the forecast period (2022-2028).
Omega-3 fatty acids are polyunsaturated fatty acids, often known as omega-3 or n-3 fatty acids (PUFAs). The family of essential oils that must obtain from food includes omega-3 fatty acids. The three most significant forms are EPA, DHA, and ALA (alpha-linolenic acid) (eicosapentaenoic acid). While DHA and EPA are primarily present in animal foods and algae, ALA is primarily found in plants.
The body needs omega-3 fatty acids to perform at its best, and they may also have a host of other potent health advantages, like enhancing heart health, lowering liver fat, promoting newborn brain development, avoiding dementia, reducing inflammation, etc. Walnuts, fish oils, chia seeds, flax seeds, fatty fish, flaxseed oil, and flaxseeds are just a few examples of foods that are frequently high in omega-3 fatty acids. An omega-3 dietary supplement, such as fish oil, is advised for persons who do not consume a lot of these foods.
It has been demonstrated that omega-3 fatty acids, such as those in fish oils and other supplements, are helpful for those with dry eyes. Meibomian Gland Dysfunction appears to be the primary cause of most dry eye conditions (MGD). When a person has MGD, the protective oil in their tears is prevented from reaching the eye's surface, which causes them to evaporate too quickly.
In China, consumer health had rapid value growth in 2018. The trend of healthy living among many customers in the nation is a major driver of the growth. Regional consumers prioritized physical health despite the fast-paced nature of modern civilization, self-medicating with OTC items from a variety of categories, including analgesics, digestive aids, cough, cold, and allergy cures, dermatological products, and sleep aids. Due to rapid growth in the demand from the working-age population disease and school/university students, dry eye treatment devices accounted for the greatest value in China's standard eye product care market.
The China market dominated the Asia Pacific Dry Eye Treatment Devices Market by Country in 2021; thereby, achieving a market value of $27.2 million by 2028. The Japan market is obtained to grow at a CAGR of 7.5% during (2022 - 2028). Additionally, The India market would exhibit CAGR of 8.8% during (2022 - 2028).
Based on Technology, the market is segmented into Meibomian Gland Expression (MGX), Broadband light (BBL), Intense Pulsed Light (IPL) and Combination (MGX+IPL). Based on End User, the market is segmented into Ophthalmic Clinics, Hospitals and Others. Based on countries, the market is segmented into China, Japan, India, Australia, South Korea, Singapore, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Dry Eye Treatment Devices Market is Projected to reach USD 348.8 Million by 2028, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiBo Medical Group, Sight Sciences, Inc., Lumenis Ltd., ESW Vision SAS, Johnson & Johnson Vision Care, Inc. and Alcon, Inc.
By Technology
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
